Results 231 to 240 of about 8,631,498 (387)

Analytical goals in therapeutic drug monitoring [PDF]

, 1998
Larry D. Bowers
openalex   +1 more source

Observational Study of Tocilizumab in Children With Febrile Infection‐Related Epilepsy Syndrome

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to assess the efficacy and safety of using tocilizumab in children with febrile infection‐related epilepsy syndrome (FIRES) and explore tocilizumab‐related changes in interleukin (IL)‐6 levels. Methods Patients with FIRES admitted to the Intensive Care Unit (ICU) of Beijing Children's Hospital were retrospectively ...
Yushan He, Jie Wu, Chaonan Fan, Zheng Li, Jun Liu, Kechun Li, Quan Wang, Suyun Qian   +7 more
wiley   +1 more source

Fighting abuse with prescription tracking: mandatory drug monitoring and intimate partner violence. [PDF]

J Popul Econ
Dave D, Erten B, Hummel D, Keskin P, Zhang S.   +4 more
europepmc   +1 more source

Standards of laboratory practice: cardiac drug monitoring [PDF]

, 1998
Roland Valdes, Saeed A. Jortani, Mihai Gheorghiade   +2 more
openalex   +1 more source

The Comparative Effectiveness and Tolerability of Sphingosine‐1‐Phosphate Receptor Modulators in Patients With Multiple Sclerosis: A Network Meta‐Analysis of Randomized Controlled Trials

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Sphingosine‐1‐phosphate receptor modulators (S1PRM) are used to treat relapsing multiple sclerosis (MS). Each drug has a different S1PR‐subtype selectivity. They target the G‐protein coupled S1P receptors and exert significant immunomodulatory effects, such as preventing the formation of new CNS lesions and the reactivation of pre ...
Faizan Shahzad, Taimoon Rasheed, Momina Riaz Siddiqui, Hamza Hamid, Marwah Bintay Khalid, Haroon Shabbir, Besher Shami, Abdullah, Syed Ijlal Ahmed   +8 more
wiley   +1 more source

Web-based automated therapeutic drug monitoring application for precision medicine in tuberculosis management. [PDF]

Transl Clin Pharmacol
Choi YK, Jayanti RP, Uyen NTH, Cho YS, Shin JG.   +4 more
europepmc   +1 more source

Standards of laboratory practice: analgesic drug monitoring [PDF]

, 1998
Suzanne White, Steven Wong
openalex   +1 more source

Real‐World Comparison of High‐Efficacy Versus Non‐High‐Efficacy Therapies in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The choice of the first disease modifying treatment (DMT) in multiple sclerosis (MS) is a topic of great interest, and whether high‐efficacy DMTs should be the first choice remains debated. We compared treatment outcomes (no evidence of disease activity [NEDA] and its components) between treatment‐naïve relapsing–remitting MS (RRMS ...
Sarmad Al‐Araji, Marcello Moccia, Alessia Bianchi, Charmaine Yam, Weaam Hamed, Suraya Mohamud, Alan J. Thompson, Frederik Barkhof, Ahmed T. Toosy, Olga Ciccarelli   +9 more
wiley   +1 more source

Saliva as a matrix for therapeutic drug monitoring and disease biomarkers in children and adolescents. [PDF]

Pharmacol Rep
Resztak M, Czyrski A, Sobiak J.
europepmc   +1 more source

Therapeutic drug monitoring in a developing country: an overview [PDF]

, 1999
Gogtay, Kshirsagar, Dalvi
openalex   +1 more source